Saba Capital and Boaz Weinstein Report Two ECAT Stock Sales
Rhea-AI Filing Summary
Saba Capital Management, L.P. and individual reporting person Boaz Weinstein filed a Form 4 disclosing sales of common stock of BlackRock ESG Capital Allocation Term Trust (ECAT). On 09/09/2025 they reported a sale of 76,416 shares at $16.69 and on 09/10/2025 a sale of 109,895 shares at $16.70. Following those sales the reporting entities beneficially owned 27,988,930 and 27,879,035 shares, respectively. The form is signed and dated 09/11/2025.
Positive
- Timely disclosure of insider transactions with signatures dated 09/11/2025
- Clear reporting of exact share counts and sale prices for each transaction
Negative
- Significant dispositions totaling 186,311 shares sold (76,416 and 109,895)
- Reduction in beneficial ownership shown by post-transaction holdings (27,988,930 and 27,879,035)
Insights
TL;DR: Directors/10% owners reported two disclosed stock sales totaling 186,311 shares at ~$16.69–$16.70 per share.
The filings show compliant Section 16 reporting for disposals on 09/09/2025 and 09/10/2025 by Saba Capital Management, L.P. and Boaz Weinstein. The transactions are recorded as dispositions (code S) with post-transaction beneficial ownership levels documented. No derivative transactions or other compensatory grants are reported. The disclosure provides clear quantities, prices, and resulting ownership figures necessary for investor monitoring of insider activity.
TL;DR: Timely Form 4 discloses insider sales and updated beneficial ownership; no further context or plans provided.
The document identifies reporting persons as directors and 10% owners and includes manual signatures dated 09/11/2025, indicating formal completion. The report lists two open-market sale transactions (S code) with explicit share counts and prices and shows only indirect beneficial ownership after the sales. There is no amendment, no derivative activity, and no explanatory plan language included on the form.
FAQ
What insider transactions were reported for ECAT?
Who filed the Form 4 for ECAT?
What were the beneficial ownership levels after the reported sales?
Were any derivative securities reported on this Form 4?
Are the sales coded as open-market transactions or part of a plan?